MUC1 and interstitial lung disease: Several biomarkers such as CRP, MPO-ANCA, and KL-6, BVAS, and PFT findings were not different between survivors and non-survivors of MPO-ANCA positive MPA-ILD, whereas bilateral lower lobe fibrosis scores were significantly higher in the non-survivors.